|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| A01N 43/04 | |||
| C07H 21/04 | |||
| A61K 31/07 | |||
| C12N 15/113 |
| (11) | Patento numeris | 2584047 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12178664.4 |
| Europos patento paraiškos padavimo data | 2007-05-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-04-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-11-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 799458 P | 2006-05-11 | US | |
| 817203 P | 2006-06-27 | US | |
| 840089 P | 2006-08-25 | US | |
| 829914 P | 2006-10-18 | US | |
| 901134 P | 2007-02-13 | US |
| (72) |
Tan, Pamela, US
Bramlage, Birgit, US
Frank-Kamenetsky, Maria, US
Fitzgerald, Kevin, US
Akinc, Akin, US
Kotelianski, Victor E., US
|
| (73) |
Alnylam Pharmaceuticals Inc.,
300 Third Street, Cambridge, MA 02142,
US
|
| (54) | Compositions and methods for inhibiting expression of the PCSK9 gene |
| Compositions and methods for inhibiting expression of the PCSK9 gene |